`
Monday, 26 June 2017

India News

  • Singapore's Fortis Surgical Hospital is now Concord Medical Services

    India |  News | By BioSpectrum Bureau | 0 Comment | 16 Oct, 2015

    Singapore: Concord Medical Services, China based hospital management solution provider, has received Singapore's approval to change the name of the Fortis Surgical Hospital, which was acqui...Read more

  • Cipla, Alembic contest Indian drug pricing in court

    India |  News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013

    Singapore: Miffed at Indian government's move to slash prices of essential medicines through the new drug pricing policy, drug makers Cipla and Alembic have now moved court. The Indian gov...Read more

  • India's AYUSH becomes popular in Asia

    India |  News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2015

    Singapore: With the ancient Indian medicine systems AYUSH (Ayurveda, Yoga, Unani, Siddha and Homeopathy) gaining popularity in Asian countries, the Ministry of AYUSH is receiving requests t...Read more

  • Quintiles and Biogen Idec ink pact

    India |  News | By BioSpectrum Bureau | 0 Comment | 05 May, 2014

    Singapore: Quintiles and US-based biotech company Biogen Idec have entered into a five-year strategic clinical development agreement. The multi-year collaboration is designed to leverage t...Read more

  • Biocon launches world's first Biosimilar 'CANMAb' in India

    India |  News | By BioSpectrum Bureau | 0 Comment | 20 Jan, 2014

    Bangalore: CANMAb has been jointly developed by Biocon in partnership with Mylan and it is said to be the world's first biosimilar version of Herceptin. At the launch this morning, Dr Kira...Read more

  • Piramal to acquire US-based Decision Resource Group

    India |  News | By BioSpectrum Bureau | 0 Comment | 17 May, 2012

    Mumbai: Piramal Healthcare, an innovation led company, has agreed to acquire Decision Resources Group (DRG) a US-based company in the healthcare information segment, from Providence Equity ...Read more

  • Cadila Healthcare eyeing US, Europe markets

    India |  News | By BioSpectrum Bureau | 0 Comment | 15 Sep, 2014

    Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon start filings for approval of its innovator drug Lipaglyn there. As per ...Read more

  • Indian drug dealers worried about $1.69 bn old stocks

    India |  News | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013

    New Delhi: Ahead of the Drug Price Control Order (DPCO) to revise drug prices that came into effect on July 29, medicine wholesalers and retailers have warned of many repercussions. The mos...Read more

  • Dr Reddy's launch cystic acne generic Zenatane

    India |  News | By BioSpectrum Bureau | 0 Comment | 02 Apr, 2013

    Hyderabad: Dr. Reddy's Laboratories launched Zenatane (isotretinoin) capsules in 20 mg and 40 mg in the US. The drug is a therapeutically equivalent generic version of Accutane. The drug...Read more

  • Transasia gets award from the President of India

    India |  News | By BioSpectrum Bureau | 0 Comment | 26 Oct, 2012

    New Delhi: Transasia BioMedicals, one of India's largest IVD companies, was recently conferred with the coveted 'Niryat Shree' Gold trophy by the President of India, Pranab Mukherjee . Inst...Read more

  • FIPB approves investments worth $143.43 mn

    India |  News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2013

    Singapore: The Foreign Investment Promotion Board (FIPB) in India cleared six investment proposals in the pharmaceutical sector on July 29. The total worth of the projects that were cleared...Read more

  • Dr. Reddy's generic of Revatio (sildenafil) now available in US

    India |  News | By BioSpectrum Bureau | 0 Comment | 20 Nov, 2012

    Hyderabad: Dr. Reddy's Laboratories has launched sildenafil tablets (20 mg), a bioequivalent generic version of Revatio tablets in the US market. Revatio is indicated for the treatment of...Read more

  • First generic versions of Cymbalta receive FDA nod

    India |  Regulatory | By BioSpectrum Bureau | 0 Comment | 13 Dec, 2013

    Singapore: US Food and Drug Administration has approved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and ot...Read more

  • Sri Lanka again bans drug imports from Indian firms

    India |  News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2013

    Singapore: Sri Lanka's Ministry of Health has decided to ban the purchase of drugs from four Indian pharmaceutical companies, including Laborate, Vivek, Bafna and Elysium Pharma, due to inc...Read more

  • Medicines: Veg or Non-veg?

    India |  News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2015

    Singapore: If reports are to be believed, vegetarian and non-vegetarian capsules will soon hit the Indian market, offering new choice to patients. According to a report by a leading daily,...Read more

  • India's CSIR to research on medicinal properties of cow urine

    India |  News | By BioSpectrum Bureau | 0 Comment | 27 Jul, 2015

    Singapore: Indian Council of Scientific and Industrial Research (CSIR) through its constituent laboratories has conducted research studies in collaboration with Go Vigyan Anusandhan Kendra...Read more

  • Study: Infrastructure, policy are biggest hurdles in India

    India |  News | By BioSpectrum Bureau | 0 Comment | 25 Jun, 2013

    New Delhi: The McKinsey report, commissioned by the US-India Chamber of Commerce, was released at the recently held US-India BioPharma and Healthcare Summit 2013 in Boston, US. The report p...Read more

  • Boehringer drug gets Frost brand of the year award

    India |  News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2013

    Singapore: Frost & Sullivan (F&S) has awarded Boehringer Ingelheim (BI) the 'Pharmaceutical Brand of the Year - New Launch 2013' award for its most appreciated product Trajenta at t...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls